Entity Common Stock, Shares Outstanding of Panbela Therapeutics, Inc. from 25 Mar 2013 to 11 Nov 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Panbela Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 25 Mar 2013 to 11 Nov 2024.
  • Panbela Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2024 was 4,854,831, a 5.3% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Panbela Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 4,854,831 -272,855 -5.3% 11 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 4,854,861 +1,897,125 +64% 09 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 4,854,861 -9,741,012 -67% 22 Mar 2024 10-K 26 Mar 2024 2023 FY
Q3 2023 5,127,686 -26,584,276 -84% 07 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 2,957,736 -17,816,309 -86% 07 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 14,595,873 +1,146,756 +8.5% 13 Mar 2023 10-K 16 Mar 2023 2022 FY
Q3 2022 31,711,962 +18,277,810 +136% 08 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 20,774,045 +7,345,288 +55% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 13,449,117 +3,365,245 +33% 22 Mar 2022 10-K 24 Mar 2022 2021 FY
Q3 2021 13,434,152 +3,784,725 +39% 08 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 13,428,757 +6,360,449 +90% 09 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 10,083,872 +3,452,564 +52% 23 Mar 2021 10-K 25 Mar 2021 2020 FY
Q3 2020 9,649,427 +3,018,119 +46% 11 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 7,068,308 +1,346,209 +24% 07 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 6,631,308 +1,560,967 +31% 20 Mar 2020 10-K 24 Mar 2020 2019 FY
Q3 2019 6,631,308 +1,570,714 +31% 08 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 5,722,099 +661,505 +13% 10 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 5,070,341 +976,489 +24% 15 Mar 2019 10-K 22 Mar 2019 2018 FY
Q3 2018 5,060,594 +1,390,151 +38% 03 Nov 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 5,060,594 -31,644,045 -86% 13 Aug 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 4,093,852 -28,157,454 -87% 19 Mar 2018 10-K 21 Mar 2018 2017 FY
Q3 2017 3,670,443 -28,505,863 -89% 10 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 36,704,639 +4,823,333 +15% 07 Aug 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 32,251,306 +2,358,500 +7.9% 27 Mar 2017 10-K 30 Mar 2017 2016 FY
Q3 2016 32,176,306 +2,283,500 +7.6% 07 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 31,881,306 +30,430,984 +2098% 08 Aug 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 29,892,806 +28,442,484 +1961% 01 Mar 2016 10-K 08 Mar 2016 2015 FY
Q3 2015 29,892,806 +28,442,484 +1961% 11 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 1,450,322 0 0% 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 1,450,322 0 0% 30 Mar 2015 10-K 30 Mar 2015 2014 FY
Q3 2014 1,450,322 0 0% 10 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 1,450,322 0 0% 13 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 1,450,322 0 0% 21 Mar 2014 10-K 28 Mar 2014 2013 FY
Q3 2013 1,450,322 14 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 1,450,322 14 Aug 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 1,450,322 25 Mar 2013 10-K 26 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.